Investments
26Portfolio Exits
9Funds
2About Cogene Ventures
Cogene Ventures is a life-sciences and medical-technology venture capital firm with an investment focus on biopharmaceuticals and biotechnology platforms that enable better, faster and cheaper therapeutic drug discovery. Other areas of investment focus include bio-nanotechnology, therapeutic medical devices and health-care IT/software. With approximately $50 million under management, Cogene's investments range in size from $200,000 to $5 million with two portfolio companies, Lexicon Genetics (NASDAQ: LEXG) and Informax (NASDAQ: INMX), currently trading in the public markets. The president and CEO of Cogene Biotech Ventures is Dr. C. Thomas Caskey, the former SVP of Research at Merck, a member of the National Academy of Sciences and one of the nation's most respected experts on genomics.
Want to inform investors similar to Cogene Ventures about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Cogene Ventures Investments
26 Investments
Cogene Ventures has made 26 investments. Their latest investment was in MacroGenics as part of their Series E on January 1, 2011.
Cogene Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
1/31/2011 | Series E | MacroGenics | $12.02M | No | Alta Partners, Biogen Idec New Ventures, Caisse de depot et placement du Quebec, CIDC, Cogene Ventures, Covera Ventures, Hunt BioVentures, InterWest Partners, Mithra Group, Mitsubishi UFJ Capital, MPM Capital, Nextech Venture, OrbiMed Advisors, Presidio Partners, Red Abbey Venture Partners, RiverVest Venture Partners, STARTech Early Ventures, TPG Biotech, Ventures West, and Vivo Capital | |
3/6/2010 | Series C | Odyssey Thera | $3.5M | No | ||
10/13/2006 | Unattributed VC - II | MedServe | $70M | No | ||
10/17/2005 | Series B | |||||
10/13/2005 | Series D |
Date | 1/31/2011 | 3/6/2010 | 10/13/2006 | 10/17/2005 | 10/13/2005 |
|---|---|---|---|---|---|
Round | Series E | Series C | Unattributed VC - II | Series B | Series D |
Company | MacroGenics | Odyssey Thera | MedServe | ||
Amount | $12.02M | $3.5M | $70M | ||
New? | No | No | No | ||
Co-Investors | Alta Partners, Biogen Idec New Ventures, Caisse de depot et placement du Quebec, CIDC, Cogene Ventures, Covera Ventures, Hunt BioVentures, InterWest Partners, Mithra Group, Mitsubishi UFJ Capital, MPM Capital, Nextech Venture, OrbiMed Advisors, Presidio Partners, Red Abbey Venture Partners, RiverVest Venture Partners, STARTech Early Ventures, TPG Biotech, Ventures West, and Vivo Capital | ||||
Sources |
Cogene Ventures Portfolio Exits
9 Portfolio Exits
Cogene Ventures has 9 portfolio exits. Their latest portfolio exit was Helsinn on August 06, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
8/6/2021 | Acquired | 2 | |||
Date | 8/6/2021 | ||||
|---|---|---|---|---|---|
Exit | Acquired | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 2 |
Cogene Ventures Fund History
2 Fund Histories
Cogene Ventures has 2 funds, including Cogene Biotech Ventures II LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
10/31/2004 | Cogene Biotech Ventures II LP | Late-Stage Venture Capital | Closed | $157M | 1 |
6/1/2000 | Cogene Biotech Ventures LP |
Closing Date | 10/31/2004 | 6/1/2000 |
|---|---|---|
Fund | Cogene Biotech Ventures II LP | Cogene Biotech Ventures LP |
Fund Type | Late-Stage Venture Capital | |
Status | Closed | |
Amount | $157M | |
Sources | 1 |
Cogene Ventures Team
6 Team Members
Cogene Ventures has 6 team members, including current Chief Financial Officer, Kathy Mattina.
Name | Work History | Title | Status |
|---|---|---|---|
Kathy Mattina | Chief Financial Officer | Current | |
Name | Kathy Mattina | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Chief Financial Officer | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
